USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
GLYCOSENSORS AND DIAGNOSTICS, LLC
Address:
GLYCOSENSORS AND DIAGNOSTICS, LLC
ATHENS, GA 30602-1514
Phone:
N/A
URL:
EIN:
136462066
DUNS:
808436633
Number of Employees:
4
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $248,819.00 2
SBIR Phase II $999,970.00 1
STTR Phase I $200,361.00 1
STTR Phase II $1,462,149.00 1

Award List:

High-specificity affinity reagents for N-glycosylation site mapping and glycomics

Award Year / Program / Phase:
2009 / STTR / Phase I
Award Amount:
$200,361.00
Agency:
HHS
Principal Investigator:
Research Institution:
UNIVERSITY OF GEORGIA (UGA)
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): Glycans have several distinct properties that make them excellent targets for disease biomarkers. Firstly, the location of the glycans on the cell surface makes them the first point of contact of cellular interactions a nd thus crucial in the control of normal… More

SBIR TOPIC 294 PHASE 1 - DEVELOPMENT OF GLYCOSYLATION - SPECIFIC RESEARCH

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$148,851.00
Agency:
HHS
Principal Investigator:
Lori Yang – 706-549-4484
Abstract:
The long term objectives of this proposal are to demonstrate the utility of a new class of high-specificity high-affinity proteins called Lectenz as research reagents for use in recognition of disease- or cancer-related glycosylation sites. The specific aims are to create a reagent that is… More

In-process glycoprofiling during recombinant therapeutic glycoprotein production

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$99,968.00
Agency:
HHS
Principal Investigator:
Loretta Yang – 706-542-4454
Abstract:
DESCRIPTION (provided by applicant): The biologics market is the most rapidly growing sector of the pharmaceutical industry, and the US Food and Drug Administration (FDA), as well as the European Medicines Agency (EMEA), requires that the glycoprofiles ofall such therapeutic glycoproteins and… More

High-specificity affinity reagents for N-glycosylation site mapping and glycomics

Award Year / Program / Phase:
2013 / STTR / Phase II
Award Amount:
$1,462,149.00
Agency:
HHS
Principal Investigator:
Robert J. Woods – 706-542-4454
Research Institution:
UNIVERSITY OF GEORGIA RESEARCH FOUNDATION
RI Contact:
Abstract:
DESCRIPTION: Glycans have several distinct properties that make them excellent targets for disease biomarkers. Firstly, the location of the glycans on the cell surface makes them the first point of contact of cellular interactions and thus crucial in thecontrol of normal metabolic processes. Cell… More

SBIR PHASE II TOPIC 294: DEVELOPMENT OF RESEARCH REAGENTS SPECIFIC FOR O-GLCNAC (

Award Year / Program / Phase:
2013 / SBIR / Phase II
Award Amount:
$999,970.00
Agency:
HHS
Principal Investigator:
Lori Yang – 706-549-4484
Abstract:
Not Available